Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Trading Down 7.9% – What’s Next?

Shares of Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) dropped 7.9% during trading on Wednesday . The company traded as low as $20.55 and last traded at $20.55. Approximately 9,723 shares were traded during mid-day trading, an increase of 243% from the average daily volume of 2,831 shares. The stock had previously closed at $22.3125.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada raised Fisher & Paykel Healthcare to a “sector perform” rating in a research note on Tuesday, February 24th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Fisher & Paykel Healthcare presently has a consensus rating of “Hold”.

Fisher & Paykel Healthcare Stock Performance

The firm has a 50-day simple moving average of $22.80 and a 200 day simple moving average of $22.13.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.